Prionics Acquires Pfizer Animal Health's Diagnostic Products
The product line includes tests for the detection of Bovine tuberculosis (Bovigam(R)) and Paratuberculosis (Parachek(R)) in animals raised as a food source. Both diseases cause major economic damage to the farm industry and also have implications to human health.
Bovigam(R) and Parachek(R) are among the leading products in their field with significant shares in existing markets and an attractive potential for the development of new markets. Prionics will fully integrate the diagnostic tests into its product portfolio through a one year transition phase to ensure a smooth changeover.
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.